azacitidine has been researched along with Preleukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Azizi, A; Bergamaschi, A; Corces, MR; Cruz Hernandez, D; Dutta, R; Ediriwickrema, A; Ellison, CK; Fan, A; Guler, GD; Karigane, D; Kaur, S; Köhnke, T; Ku, CJ; Levy, S; Majeti, R; Martinez-Krams, D; McCarthy, E; Nakauchi, Y; Ning, Y; Phan, P; Phillips, T; Reinisch, A; Sharma, R; Stafford, M; Thomas, D | 1 |
Jehn, U | 1 |
1 trial(s) available for azacitidine and Preleukemia
Article | Year |
---|---|
Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Opportunistic Infections; Patient Acceptance of Health Care; Preleukemia; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
1 other study(ies) available for azacitidine and Preleukemia
Article | Year |
---|---|
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia.
Topics: Azacitidine; Chromatin; Dioxygenases; DNA-Binding Proteins; Hematopoiesis; Humans; Myelodysplastic Syndromes; Preleukemia; Proto-Oncogene Proteins | 2022 |